Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice [Yahoo! Finance]
Protagenic Therapeutics, Inc. (PTIX)
US:NASDAQ Investor Relations:
protagenic.com/investors
Company Research
Source: Yahoo! Finance
Nasdaq Listing Rule 5550(a)(2) as the closing bid price of shares of PTIX has remained above $1.00 per share for ten consecutive trading days. This resolves the issue of potential delisting from Nasdaq by May 19, 2024 that the company had been facing. On Tuesday, November 21, 2023, the company received a deficiency letter from Nasdaq stating that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market, because it had not maintained a minimum bid price of $1.00 per share for 30 consecutive trading days. The Notification Letter stated that the company had 180 calendar days, or until May 19, 2024, to regain compliance by having a closing bid price of at least $1.00 per share for ten consecutive trading days. On March 19, 2024, the company received a formal notice from Nasdaq confirming that it has regained compliance with Listing Rule 5550(a)(2). About Protagenic Therapeutics, Inc.:
Show less
Read more
Impact Snapshot
Event Time:
PTIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTIX alerts
High impacting Protagenic Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PTIX
News
- Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit [Yahoo! Finance]Yahoo! Finance
- Protagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston SummitAccesswire
- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]Yahoo! Finance
- Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 ResultsAccesswire
PTIX
Sec Filings
- 4/24/24 - Form 10-K/A
- 4/1/24 - Form 4
- 4/1/24 - Form 10-K
- PTIX's page on the SEC website